Drug Price Trends for ERYTHROMYCIN-BENZOYL GEL

Average Pharmacy Cost for ERYTHROMYCIN-BENZOYL GEL

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
ERYTHROMYCIN-BENZOYL GEL	64980-0328-02	0.85009	GM	2024-12-18
ERYTHROMYCIN-BENZOYL GEL	68682-0901-46	0.85009	GM	2024-12-18
ERYTHROMYCIN-BENZOYL GEL	68682-0900-23	1.62361	GM	2024-12-18
ERYTHROMYCIN-BENZOYL GEL	64980-0328-01	1.62361	GM	2024-12-18
ERYTHROMYCIN-BENZOYL GEL	64980-0328-02	0.78364	GM	2024-11-20

ERYTHROMYCIN-BENZOYL GEL Market Analysis and Financial Projection

Market Analysis and Price Projections for Erythromycin-Benzoyl Peroxide Gel

Introduction

Erythromycin-benzoyl peroxide gel, commonly known by brand names such as Benzamycin, is a topical acne treatment that combines the antibacterial properties of erythromycin with the keratolytic and antibacterial effects of benzoyl peroxide. This article provides a comprehensive market analysis and price projections for this medication.

Market Overview

The global market for erythromycin, including its various formulations such as the erythromycin-benzoyl peroxide gel, is driven by several key factors.

Increasing Prevalence of Bacterial Infections

The rising incidence of bacterial infections, including skin and respiratory tract infections, significantly drives the demand for erythromycin-based treatments. According to the World Health Organization, lower respiratory infections were the fourth leading cause of death globally in 2019, highlighting the persistent need for effective antibiotics like erythromycin[3].

Efficacy in Acne Treatment

Studies have shown that erythromycin-benzoyl peroxide gel is highly effective in treating acne vulgaris. A randomized 10-week study demonstrated that this gel was more effective than erythromycin-zinc solution in reducing inflammatory lesions and comedones, with significant improvements observed as early as week 2[1].

Market Size and Growth

The global erythromycin market, which includes the erythromycin-benzoyl peroxide gel, was valued at USD 15.3 billion in 2023 and is expected to grow to USD 26.0 billion by 2033, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period from 2024 to 2033[3].

Regional Dynamics

North America is expected to hold a dominant position in the erythromycin market, driven by rising regulatory approvals and the increasing prevalence of skin and soft tissue infections. Europe and the Asia Pacific region also contribute significantly to the market, with Europe holding around 25% and the Asia Pacific region accounting for about 30% of the global market[3][4].

Price Projections

The cost of erythromycin-benzoyl peroxide gel can vary based on the quantity and the pharmacy.

Current Pricing

• For a supply of 23.3 grams, the cost is around $63.56.
• For a supply of 46.6 grams, the cost is approximately $75.31[2][5].

Factors Influencing Pricing

• Generic Competition: The availability of generic versions of erythromycin-benzoyl peroxide gel has led to intense price competition, which benefits consumers but reduces profit margins for manufacturers[3][4].
• Regulatory Approvals: Recent FDA approvals for generic versions of erythromycin-benzoyl peroxide gel, such as the one by Rising Pharmaceuticals, Inc., have increased market competition and potentially lowered prices[4].
• Patient Assistance Programs: Although no specific patient assistance programs are available for this medication, the use of discount cards and copay programs can significantly reduce the cost for patients[2][5].

Competitive Analysis

The market for erythromycin-benzoyl peroxide gel is competitive, with several key players involved in its development, manufacturing, and marketing.

Key Players

• Ani Pharmaceuticals
• Akorn, Inc.
• Aceto Corporation
• Genesis Pharmaceuticals
• Teligent, Inc.
• Abbvie, Inc.
• Abbott Laboratories
• Pfizer, Inc.
• Sanofi-Aventis
• Allergan, Plc.[4]

These companies are focused on increasing access to affordable medications and developing new formulations, which can impact pricing and market dynamics.

Growth Opportunities

Expansion in Emerging Markets

Emerging markets, particularly in countries like India and China, offer significant growth opportunities due to rapid improvements in healthcare access and a growing pharmaceutical market. Erythromycin-benzoyl peroxide gel can serve as a cost-effective alternative in these regions, where antibiotic resistance is rising[3].

Ongoing Research and Development

Continuous research and development of new formulations and delivery methods for erythromycin-benzoyl peroxide gel can drive market growth. For instance, the launch of new generic versions and the approval of new drug applications by regulatory agencies can expand market reach and reduce costs[4].

Challenges

Antibiotic Resistance

The increasing prevalence of antibiotic resistance poses a significant challenge to the erythromycin market. This can lead to reduced efficacy and increased demand for alternative antibiotics, potentially affecting the market size and pricing of erythromycin-benzoyl peroxide gel[3][4].

Regulatory Hurdles

Stringent regulatory approvals and the need for ongoing clinical research to ensure safety and efficacy can also hinder market growth and impact pricing strategies[3].

Key Takeaways

• Market Growth: The global erythromycin market, including the erythromycin-benzoyl peroxide gel, is expected to grow at a CAGR of 5.6% from 2024 to 2033.
• Pricing: The cost of erythromycin-benzoyl peroxide gel varies, with a supply of 23.3 grams costing around $63.56 and 46.6 grams costing approximately $75.31.
• Competitive Landscape: The market is competitive, with several key players involved in the development and marketing of the gel.
• Growth Opportunities: Expansion in emerging markets and ongoing research and development offer significant growth opportunities.
• Challenges: Antibiotic resistance and regulatory hurdles are key challenges facing the market.

FAQs

What is the primary use of erythromycin-benzoyl peroxide gel?

Erythromycin-benzoyl peroxide gel is primarily used for the treatment of acne vulgaris.

How effective is erythromycin-benzoyl peroxide gel in treating acne?

Studies have shown that erythromycin-benzoyl peroxide gel is highly effective in reducing inflammatory lesions and comedones, with significant improvements observed as early as week 2[1].

What are the key factors driving the market growth for erythromycin-benzoyl peroxide gel?

The market is driven by the increasing prevalence of bacterial infections, the efficacy of the gel in treating acne, and expansion in emerging markets[3].

How does generic competition affect the pricing of erythromycin-benzoyl peroxide gel?

Generic competition has led to intense price competition, reducing the cost for consumers but also reducing profit margins for manufacturers[3][4].

What are the challenges facing the erythromycin-benzoyl peroxide gel market?

The key challenges include antibiotic resistance and stringent regulatory approvals[3].

Sources

1. Comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel with erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris. British Journal of Dermatology, 136(2), 235-238.
2. Benzoyl peroxide/erythromycin topical Prices, Coupons, Copay Cards & Patient Assistance. Drugs.com.
3. Erythromycin Market Size, Share, Growth | CAGR of 5.6%. Market Research Biz.
4. Erythromycin Market - Share, Size and Industry Analysis. Coherent Market Insights.
5. Benzamycin Prices, Coupons, Copay Cards & Patient Assistance. Drugs.com.